Challenge: The client is an innovative pharmaceutical company from Taiwan that is developing a transdermal patch for the treatment of Alzheimer’s disease, with plans to launch the product in the U.S. market within the next five years. However, due to a lack of knowledge about the U.S. market and legal requirements, the client is uncertain about how to enter the market. Additionally, the client seeks to better understand the product’s market value to gain a stronger negotiating position in future partnerships.
Solution: We conducted market and sales research to identify market opportunities and developed an interview schedule. Through preliminary research and interviews with relevant stakeholders, we clarified the pricing strategy and identified entry barriers while analyzing similar therapies to understand the product’s market positioning. We then summarized the findings from both the initial and secondary research, determining the product’s value and market positioning, and created a net present value (NPV) model for the product, which included the best-case, worst-case, and normal-case scenarios.
Outcome: Our client gained a clear understanding of the product’s commercial value. With our assistance, they established an NPV model and estimated the market value to be approximately $3 million. As a result, the client decided to select us as their consulting advisor and negotiated a partnership agreement.